You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Monoclonal Antibodies

Showing 26 - 50 of 7,894
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

COVID-19 Infection, Hematopoietic and Lymphoid Cell Tumor, Malignant Solid Tumor Trial in Seattle (Questionnaire Administration,

Suspended
  • COVID-19 Infection
  • +2 more
  • Questionnaire Administration
  • Sotrovimab
  • Seattle, Washington
    Fred Hutch/University of Washington Cancer Consortium
Jan 24, 2023

Infusion Reaction, Monoclonal Antibody Trial in Clovis (Montelukast 10 Mg Oral Tablet)

Recruiting
  • Infusion Reaction
  • Monoclonal Antibody
  • Montelukast 10 Mg Oral Tablet
  • Clovis, California
    Community Cancer Institute
Nov 8, 2021

Alzheimer Trial in United States (Anti-amyloid Monoclonal Antibodies (mAbs), Standard of Care)

Not yet recruiting
  • Alzheimer Disease
  • Anti-amyloid Monoclonal Antibodies (mAbs)
  • Standard of Care
  • Albany, Georgia
  • +7 more
Aug 13, 2023

TURN-COVID Biobank: The Dutch Cohort Study for Evaluation of Use

Recruiting
  • COVID-19
  • casirivimab with imdevimab
  • +2 more
  • Amsterdam, Noord Holland, Netherlands
  • +3 more
Jan 13, 2022

Consistency of PD-L1 Detecting Method Between E1L3N and 22C3

Completed
  • Non Small Cell Lung Cancer
    • Changsha, Hunan, China
      Hunan Cancer Hospital
    Nov 20, 2021

    COVID-19 Trial in China (BRII-196 and BRII-198, Placebo)

    Completed
    • COVID-19
    • BRII-196 and BRII-198
    • Placebo
    • Beijing, Beijing, China
    • +5 more
    Mar 1, 2022

    Monoclonal Gammopathy of Uncertain Significance Trial in Utrecht (Zanubrutinib Oral Product)

    Not yet recruiting
    • Monoclonal Gammopathy of Uncertain Significance
    • Zanubrutinib Oral Product
    • Utrecht, Netherlands
      University Medical Center Utrecht
    Jul 6, 2023

    HIV/AIDS Trial in Orlando, Boston, Houston (PGT121 + VRC07-523LS, PGT121 + VRC07-523LS + PGDM1400)

    Completed
    • HIV/AIDS
    • PGT121 + VRC07-523LS
    • PGT121 + VRC07-523LS + PGDM1400
    • Orlando, Florida
    • +2 more
    May 6, 2022

    Squamous Cell Carcinoma antigen2 in Verruca Vulgaris

    Recruiting
    • Verruca Vulgaris
    • Healthy
    • Immunohistochemical staining monoclonal antibodies to SCCA2 (SERPINB4/ SCCA2 antibody)
    • Sohag, Egypt
      Sohag University
    Jun 7, 2022

    Migraine, Migraine With Aura, Migraine Without Aura Trial (Erenumab, Fremanezumab, Galcanezumab)

    Recruiting
    • Migraine
    • +4 more
    • Innsbruck, Tirol, Austria
    • +2 more
    Oct 19, 2022

    COVID-19 : Neutralizing Human Monoclonal Antibodies Against

    Completed
    • COVID
    • Blood sample
    • Lyon, France
      Hôpital de la Croix-Rousse
    Jun 17, 2021

    HIV Trial in Worldwide (VRC01, VRC01LS, VRC07-523LS)

    Completed
    Has Results
    • HIV Infections
    • VRC01
    • +2 more
    • Los Angeles, California
    • +13 more
    Dec 19, 2022

    Isolation of Human Recombinant Therapeutic Monoclonal

    Recruiting
    • Pseudomonas Aeruginosa
    • Multi-antibiotic Resistance
    • Isolation of anti-Pseudomonas antibodies from type B lymphocytes
    • Grenoble, France
      Chu Grenoble Alpes
    May 6, 2022

    Ocrelizumab in Breastmilk

    Active, not recruiting
    • Multiple Sclerosis
    • Clinically Isolated Syndrome
    • San Francisco, California
      University of California, San Francisco
    Mar 21, 2022

    COVID-19; Isolation of Neutralizing Antibodies for Therapeutics

    Active, not recruiting
    • SARS-CoV 2
    • Blood sampling
    • Grenoble, France
      UniversityGrenobleHospital
    Mar 24, 2022

    COVID-19 Trial in United States (casirivimab+imdevimab)

    Active, not recruiting
    • COVID-19
    • Anaheim, California
    • +6 more
    Jan 26, 2022

    Chronic Migraine Trial (KOS (Intranasal kinetic oscillation stimulation))

    Not yet recruiting
    • Chronic Migraine
    • KOS (Intranasal kinetic oscillation stimulation)
    • (no location specified)
    Apr 14, 2022

    Anti-IL-6 Receptor Monoclonal Antibodies on Treatment of

    Recruiting
    • Rheumatoid Arthritis
    • +3 more
      • Barcelona, Spain
        Hospital de la Santa Creu i Sant Pau
      Apr 25, 2022

      B-cell Lymphoma, B-cell Acute Lymphoblastic Leukemia Trial in Hangzhou (QN-019a, Rituximab, Cyclophosphamid)

      Recruiting
      • B-cell Lymphoma
      • B-cell Acute Lymphoblastic Leukemia
      • Hangzhou, Zhejiang, China
        The First Affiliated Hospital of Medical College of Zhejiang Uni
      May 17, 2022

      Breast Cancer Trial in Besançon (additional blood sample)

      Completed
      • Breast Cancer
      • additional blood sample
      • Besançon, France
        Centre Hospitalier Régional Universitaire
      Apr 15, 2021

      COVID-19 Trial in United States (casirivimab+imdevimab)

      Recruiting
      • COVID-19
      • Anaheim, California
      • +5 more
      Dec 6, 2021

      Relapsed and/or Refractory Multiple Myeloma (RRMM) Trial in United States (TAK-981, Mezagitamab, Daratumumab and

      Recruiting
      • Relapsed and/or Refractory Multiple Myeloma (RRMM)
      • Scottsdale, Arizona
      • +11 more
      Jan 6, 2022

      Nephrotic Syndrome Trial in Genova (Rituximab Biosimilar ABP 798, Daratumumab)

      Not yet recruiting
      • Nephrotic Syndrome
      • Genova, Italy
        IRCCS G. Gaslini
      Jan 19, 2023

      COVID-19 Trial in Minas Gerais, Bangkok, Samut Prakan (Favipiravir, Monoclonal antibodies, Ivermectin)

      Recruiting
      • COVID-19
      • Minas Gerais, Brazil
      • +3 more
      Feb 4, 2022

      Hematological Malignancies Trial in Hangzhou (NK cells/Combined Monoclonal Antibodies)

      Not yet recruiting
      • Hematological Malignancies
      • NK cells/Combined Monoclonal Antibodies
      • Hangzhou, Zhejiang, China
        The First Affiliated Hospital, College of Medicine, Zhejiang Uni
      Dec 8, 2020